EpilepsyGTx’s Post

View organization page for EpilepsyGTx, graphic

454 followers

Today we emerge from stealth mode and officially launch EpilepsyGTx!

EpilepsyGTx announces a $10M fundraise to complete the CTA-enabling nonclinical package for lead program EPY201

EpilepsyGTx announces a $10M fundraise to complete the CTA-enabling nonclinical package for lead program EPY201

businesswire.com

Vinciane Pirard

enjoy working with people - medical and public affairs projects : understand the science , atuned to context , connect the dots, focus on feasability and implementation.

4mo

Very interesting therapeutic strategy

Wow - great work on getting the funding - looks very exciting and cant wait to hear more!

Remi Dame

Associate Director Operational Quality, Cell and Gene Therapies, Eligible QP

4mo

Fantastic news! For the patients, the scientific community, and the industry! Very well done and best of luck in the future. I wish you a lot of success!

Carlo Russo

CMO & Head of Development at Genenta Science

4mo

go for it

Andy Shenker

Consultant, Rare Diseases and Gene Therapy

4mo

Well done!

Julie Huxley-Jones

Tech + Science + AI = Life Altering Treatments for Patients | Non-Executive Director

4mo

Patients need innovative treatments where there are none. Congratulations Nicolas Koebel and Simon Goldman on a bold move for patients.

Saerah Khan

Talent Operations Management and Organisational Development for Rentschler Biopharma UK - CDMO | ATMP | Learning and Development | Human Resources Management | Strategic Workforce Planning

4mo

congratulations Nicolas Koebel and Luiz Silva best of luck in this venture 👏

David Boothe

Company founder, leading new exciting projects

4mo

I’m delighted to see your announcement, Nicolas. It gives great hope to the world of epilepsy and other biotechs in Stealth Mode - my new hero!

Julie Huxley-Jones

Tech + Science + AI = Life Altering Treatments for Patients | Non-Executive Director

4mo
See more comments

To view or add a comment, sign in

Explore topics